Watch CBSN Live

Review raises concerns about women's libido drug flibanserin

There are new concerns about the safety of the only female libido drug approved by the FDA. Flibanserin, sold under the brand name Addyi, was approved last summer. Supporters called it a victory for women suffering from lower sexual desire, but a review in a medical journal questions the quality of the drug. Dr. Tara Narula joins “CBS This Morning” to discuss the findings.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.